InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Davis Andrew. Director active across 1 company, notably Ironwood Pharmaceuticals INC. In total, 9 reports have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €439k. History available since 21 November 2022. The latest transaction was disclosed on 18 November 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Davis Andrew is SVP, Chief Business Officer at Ironwood Pharmaceuticals INC (XNAS). There have been 9 filings in total, and across the 9 sampled recent filings between 2022-11-23 and 2024-11-20, the transactions are all sales, for a total of EUR 439149.